TRHC - Tabula Rasa HealthCare, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
57.55
-0.42 (-0.72%)
As of 11:54AM EST. Market open.
Stock chart is not supported by your current browser
Previous Close57.97
Open58.31
Bid57.21 x 1300
Ask57.39 x 900
Day's Range56.74 - 59.50
52 Week Range28.55 - 91.16
Volume162,469
Avg. Volume333,200
Market Cap1.178B
Beta (3Y Monthly)1.76
PE Ratio (TTM)N/A
EPS (TTM)-1.31
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est85.80
Trade prices are not sourced from all markets
  • GlobeNewswire7 days ago

    Tabula Rasa HealthCare Announces Closing of Offering of 1.75% Convertible Notes and Exercise in Full of Option to Purchase Additional Notes

    Tabula Rasa HealthCare, Inc. (TRHC) (“TRHC”) today announced the closing of its previously announced offering of $325 million principal amount of 1.75% convertible senior subordinated notes due 2026 (the “notes”), including the exercise by the initial purchasers of their option to purchase an additional $40 million principal amount of the notes, solely to cover over-allotments. The notes are convertible, at the holder’s option, at an initial conversion rate of 14.2966 shares of TRHC’s common stock per $1,000 principal amount of notes, subject to adjustment in certain circumstances. This conversion rate is equal to an initial conversion price of approximately $69.95 per share.

  • GlobeNewswire8 days ago

    Tabula Rasa Healthcare to Announce Fourth Quarter and Full Year 2018 Operating Results and Host Conference Call on Thursday, February 28, 2019

    MOORESTOWN, N.J., Feb. 11, 2019 -- Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC), a healthcare technology company advancing the field of medication safety, will release its fourth.

  • GlobeNewswire11 days ago

    Tabula Rasa HealthCare Announces Pricing of $285 Million of 1.75% Convertible Notes

    Tabula Rasa HealthCare, Inc. (TRHC) (“TRHC”) today announced the pricing of $285 million principal amount of 1.75% convertible senior subordinated notes due 2026 (the “notes”) in a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Act”). TRHC has also granted the initial purchasers of the notes an option to purchase, within a 13-day period beginning on, and including, the date on which the notes are first issued, up to an additional $40 million principal amount of the notes, solely to cover over-allotments, if any. The notes are convertible, at the holder’s option, at an initial conversion rate of 14.2966 shares of TRHC’s common stock per $1,000 principal amount of notes, subject to adjustment in certain circumstances.

  • GlobeNewswire11 days ago

    Tabula Rasa HealthCare to Present at HIMSS19

    MOORESTOWN, N.J., Feb. 08, 2019 -- Tabula Rasa HealthCare, Inc. (TRHC) (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, today announced.

  • GlobeNewswire12 days ago

    Tabula Rasa HealthCare Announces Proposed $250 Million Offering of Convertible Notes

    Tabula Rasa HealthCare, Inc. (TRHC) (“TRHC”) today announced its intention to offer, subject to market and other conditions, $250 million principal amount of convertible senior subordinated notes due 2026 (the “notes”) in a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Act”). TRHC also expects to grant the initial purchasers of the notes an option to purchase, within a 13-day period beginning on, and including, the date on which the notes are first issued, up to an additional $37.5 million principal amount of the notes, solely to cover over-allotments, if any. The notes will be senior subordinated unsecured obligations of TRHC and are expected to pay interest semi-annually and be convertible into shares of TRHC’s common stock, cash or a combination thereof at TRHC’s option.

  • What Kind Of Share Price Volatility Should You Expect For Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC)?
    Simply Wall St.14 days ago

    What Kind Of Share Price Volatility Should You Expect For Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC)?

    Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! If you own shares in Tabula Rasa Read More...

  • Business Wire15 days ago

    After the Fall – Will Stocks Spring Back?

    Investment Professionals to Gather in Philadelphia on February 7th for Annual Groundhog Investment Forum

  • GlobeNewswire15 days ago

    Tabula Rasa HealthCare Announces Upcoming Launch of MedWise™ 2.0

    MOORESTOWN, N.J., Feb. 04, 2019 -- Tabula Rasa HealthCare, Inc. (TRHC) (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, today announced.

  • GlobeNewswire18 days ago

    Tabula Rasa HealthCare’s Subsidiary Completes Implementation of Precision Dosing Software for One of the Nation’s Leading Healthcare Systems

    Tabula Rasa HealthCare, Inc. (TRHC) (TRHC), a healthcare technology company advancing the field of medication safety, today announced its newly acquired precision dosing software company DoseMe completed its largest implementation to date for one of the nation’s leading health care provider with multiple locations in New Jersey. Over a period of only a month, by working closely with the client pharmacy services team, the roll out of DoseMe’s proprietary precision dosing software DoseMeRx spanned eleven acute care hospitals and an outpatient infusion center.  DoseMe trained hundreds of the client’s staff members representing support of the new client’s commitment to innovation in the field of medication safety.

  • GlobeNewswire19 days ago

    CareKinesis, a subsidiary of Tabula Rasa HealthCare, Signs New PACE Client in Arkansas

    Tabula Rasa HealthCare, Inc. (TRHC) (TRHC), a healthcare technology company advancing the field of medication safety, today announced its subsidiary, CareKinesis, has been selected to provide comprehensive medication management services to the third PACE organization in Arkansas. CareKinesis will serve as its medication safety partner.

  • GlobeNewswirelast month

    TRHC Commends Centers for Medicare and Medicaid Services on Creation of New Opportunities for Dual Medicaid and Medicare Patients

    Tabula Rasa HealthCare, Inc. (TRHC) (TRHC), a healthcare technology company advancing the field of medication safety, issued a statement commending the Centers for Medicare and Medicaid Services (CMS) on the creation of “Ten Opportunities to Better Serve Individuals Dually Eligible for Medicaid and Medicare.” The opportunities, which were outlined in a letter to state Medicaid directors from Seema Verma, Administrator of CMS, focus on increasing individuals’ access to high quality, integrated healthcare. As mentioned in Ms. Verma’s letter, PACE provides innovative integrated care for dually eligible individuals in a comprehensive service package that supports participants to remain in their community rather than a nursing facility.

  • Tabula Rasa completes $20M acquisition of Australian medical software company
    American City Business Journalslast month

    Tabula Rasa completes $20M acquisition of Australian medical software company

    The seller is an Australian company that has developed software to help physicians and pharmacists accurately dose patients’ high-risk parenteral medications based on individual needs.

  • GlobeNewswirelast month

    Tabula Rasa HealthCare Completes Acquisition of DoseMe

    Tabula Rasa HealthCare, Inc. (TRHC) (TRHC), a healthcare technology company advancing the field of medication safety, today announced that it completed its acquisition of precision dosing software company DoseMe on January 2, 2019. DoseMe is the developer of DoseMeRx™, an advanced precision dosing tool that helps physicians and pharmacists accurately dose patients’ high-risk parenteral medications based on individual needs, resulting in significant improvements to mortality, risk, and patient outcomes. DoseMeRx’s precision dosing capabilities will combine with TRHC’s proprietary Medication Risk Mitigation (MRM) technologies to enhance and accelerate medication safety solutions and will be made available to the hospital healthcare system market and internationally.

  • CPSI vs. TRHC: Which Stock Should Value Investors Buy Now?
    Zacks2 months ago

    CPSI vs. TRHC: Which Stock Should Value Investors Buy Now?

    CPSI vs. TRHC: Which Stock Is the Better Value Option?

  • Should You Be Worried About Insider Transactions At Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC)?
    Simply Wall St.2 months ago

    Should You Be Worried About Insider Transactions At Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC)?

    It is not uncommon to see companies perform well in the years after insiders buy shares. Unfortunately, there are also plenty of examples of share prices declining precipitously after insiders Read More...

  • GlobeNewswire2 months ago

    Tabula Rasa HealthCare Appoints Kevin Boesen as Chief Sales Officer

    Tabula Rasa HealthCare, Inc. (“TRHC”) (TRHC), a healthcare technology company advancing the field of medication safety, today announced the appointment of Kevin Boesen, PharmD, as Chief Sales Officer.  In his new role, Dr. Boesen will be responsible for all direct and channel sales efforts in the United States and Canada, with a focus on expanding the adoption of TRHC’s signature product, MedWise™, into health plans, healthcare systems, Programs of All-Inclusive Care for the Elderly and other financially at-risk healthcare organizations.

  • $20 million deal: Tabula Rasa reaches agreement to buy Australian med tech company
    American City Business Journals3 months ago

    $20 million deal: Tabula Rasa reaches agreement to buy Australian med tech company

    The proposed purchase of medication safety technology company DoseMe by Tabula Rasa consists of a upfront cash payment of $10 million, and a potential additional $10 million payment in stock and cash.

  • GlobeNewswire3 months ago

    Detailed Research: Economic Perspectives on Honeywell International, Tabula Rasa Healthcare, El Pollo Loco, Acceleron Pharma, vTv Therapeutics, and 22nd Century Group — What Drives Growth in Today's Competitive Landscape

    NEW YORK, Dec. 03, 2018 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors,.

  • GlobeNewswire3 months ago

    Tabula Rasa HealthCare to Host Investor and Analyst Day on December 4, 2018

    MOORESTOWN, N.J, Nov. 27, 2018 -- Tabula Rasa HealthCare, Inc. (“TRHC”) (NASDAQ:TRHC), a healthcare technology company advancing the field of medication safety, today announced.

  • GuruFocus.com3 months ago

    Tabula Rasa Healthcare Inc (TRHC) CEO Calvin H Knowlton Bought $487,500 of Shares

    CEO of Tabula Rasa Healthcare Inc (NASDAQ:TRHC) Calvin H Knowlton bought 7,500 shares of TRHC on 11/12/2018 at an average price of $65 a share.

  • CPSI or TRHC: Which Is the Better Value Stock Right Now?
    Zacks3 months ago

    CPSI or TRHC: Which Is the Better Value Stock Right Now?

    CPSI vs. TRHC: Which Stock Is the Better Value Option?